Baskar Mannargudi

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.
  2012 DOI: 10.1158/1078-0432.CCR-11-2425
  +Save
• A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas.
  2011 DOI: 10.1158/1078-0432.CCR-11-0821
  +Save
• Nevirapine hypersensitivity.
  2010 DOI: 10.1007/978-3-642-00663-0_15
  +Save
• A study of the specificity of lymphocytes in nevirapine-induced skin rash.
  2009 DOI: 10.1124/jpet.109.157362
  +Save
• Bioactivation of minocycline to reactive intermediates by myeloperoxidase, horseradish peroxidase, and hepatic microsomes: implications for minocycline-induced lupus and hepatitis.
  2009 DOI: 10.1124/dmd.109.027292
  +Save
• Covalent binding of penicillamine to macrophages: implications for penicillamine-induced autoimmunity.
  2009 DOI: 10.1021/tx900087z
  +Save
• Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash.
  2008 DOI: 10.1021/tx800177k
  +Save
• Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats.
  2006 DOI: 10.1021/tx0601152
  +Save
• Engineering d-amino acid containing novel protease inhibitors using catalytic site architecture.
  2006 DOI: 10.1016/j.bmc.2005.08.019
  +Save
• Involvement of reactive metabolites in idiosyncratic drug reactions.
  +Save